| Name | Title | Contact Details |
|---|---|---|
Jeff Pinto |
CIO and Head of AI | Profile |
Steri-Source is a Burley, ID-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Whether you`re expecting a baby, dealing with a complex medical condition, or anything in between, our nonprofit hospitals and clinics have the people, technology, and experience you can trust. For nearly a century, Swedish has been the premier health-care provider in the Pacific Northwest and a trusted resource for people when it truly counts. Swedish is the largest nonprofit health care provider in the Greater Seattle Area. It is comprised of five hospital campuses (First Hill, Cherry Hill, Ballard, Edmonds and Issaquah); ambulatory care centers in Redmond and Mill Creek; and Swedish Medical Group a network of more than 183 primary care and specialty locations throughout the Great Puget Sound area. S wedish employs more than 13,000 employees and 4,200 physicians. Whether through physician clinics, health education, research and innovation or other means of outreach, we`re committed to caring for the people in our region and beyond. Swedish is proud to be an Equal Opportunity Employer. Swedish does not discriminate on the basis of race, color, gender, disability, protected veteran, military status, religion, age, creed, national origin, gender identity, sexual orientation, marital status, genetic information, or any other basis prohibited by local, state, or federal law
Jack Gold Surgical Appliances is a Randolph, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Xenon Pharmaceuticals (NASDAQ:XENE) – a biopharmaceutical company with operations in Vancouver, BC, Canada and Boston, MA, U.S.A. – is committed to delivering innovative medicines to provide a brighter future for patients suffering from neurological disorders. At Xenon, we are advancing an exciting pipeline of neurology-focused therapies, with a particular emphasis on novel treatments for both adult and pediatric patients with epilepsy. XEN496 is currently being evaluated in the Phase 3 “EPIK” clinical trial in young patients with KCNQ2-DEE, a rare and severe form of childhood epilepsy. Late-stage development plans are also underway for our XEN1101 program, building upon the compelling data from the Phase 2b “X-TOLE” study in adult patients with focal epilepsy. We are also proud of the leading-edge science coming out of our discovery labs, with many early-stage research programs underway. In addition to Xenon`s proprietary programs, we have ongoing collaborations with our valued pharmaceutical partners. With a healthy balance sheet to support our growth plans, we continue to build a fully-integrated, premier neuroscience company with strong discovery, development, and commercial operations. Our employees are smart, passionate, dedicated, and driven by their incredibly important work to discover, develop, and deliver new medicines for patients in need. Building and maintaining a respectful, collaborative, inclusive, and productive culture is a priority for us. We are looking for great people who thrive in a fast-paced, dynamic work environment to join our team during this transformative time for Xenon.
Ovia Health is a family health benefits platform helping women and families with personalized and data-driven solutions for fertility, pregnancy, and parenting.